We use cookies to customise content for your subscription and for analytics.
If you continue to browse Lexology, we will assume that you are happy to receive all our cookies. For further information please read our Cookie Policy.

Search results

Order by: most recent most popular relevance

Results: 1-10 of 2,894

The top 5 trends in Canadian intellectual property law for 2015
  • Bennett Jones LLP
  • Canada
  • March 3 2015

Last year promised significant changes in Canadian IP law; some of which will be realized in 2015. As the first quarter draws to a close, this year's

Hearing, seeing, moving (part 2) - key issues in regulation and protection
  • Taylor Wessing
  • United Kingdom
  • March 19 2015

Hearing, seeing, moving - the miracle of neural prosthetics explained some of the stunning developments that are occurring in the field of neural

Doing business in Russia 2015
  • Baker & McKenzie
  • Russia
  • March 12 2015

The Russian Federation stretches across Eurasia from Eastern Europe to the Pacific coast. After the collapse of the Soviet Union, Russia became the

Rx IP update 2015 mid-year highlights
  • Smart & Biggar/Fetherstonhaugh
  • Canada
  • July 16 2015

The following is a mid-year review of the top IP and regulatory law developments in life sciences in Canada. 1. Still no clarification from Supreme

Intellectual Property Linkage: Connecting IP Offices with Regulators
  • Tilleke & Gibbins
  • Thailand
  • November 30 2016

Intellectual property (IP) linkage refers to connecting an IP office, through open communication lines and complementary processes, to other

Eversheds’ life sciences group 201415 - winter legal update
  • Eversheds
  • Global
  • February 13 2015

The European Union has stated that cross-border innovation in science is being hindered by the current fragmented legal framework on the protection of

Industry news
  • Borden Ladner Gervais LLP
  • Canada
  • December 16 2014

The Patented Medicine Prices Review Board (PMPRB) has released a new report titled "Generic Drugs in Canada, 2013", which compares the prices of

IP & technology review 23 March 2015
  • Roschier
  • European Union, Finland, Sweden
  • March 23 2015

The Court of Justice of the European Union (“CJEU”) has in a recent judgment C-63113 (Arne Forsgren v. Österreichische Patentamt) held that a

The right policy prescription for pharmaceutical patents? The Australian Productivity Commission proposes a new formula
  • FPA Patent Attorneys
  • Australia
  • May 11 2016

As mentioned in our earlier article (which can be found here) Australia's Productivity Commission has released a draft report (Report) regarding

Protecting inventions in the life sciences sector
  • Krishna & Saurastri Associates LLP
  • India
  • August 29 2013

Although the life sciences industry offers huge potential for profit, rights holders must first negotiate a sensitive and complex legal framework